Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and obesi | ...

GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

A recent study by Mount Sinai researchers reveals a significant link between exposure to PFAS, commonly known as forever ...

In diabetes, much attention goes to sugar control, insulin levels, and the threat of nerve damage. But a new study reveals ...

What if the cure for a life-threatening heart condition wasn't a drug or surgery, but a supplement you could find on a store shelf? Japanese researchers have uncovered that tricaprin, a dietary ...

In short, semaglutide can help people with diabetes improve their blood sugar and lose weight. Higher doses seem to work ...

The Inflation Reduction Act (IRA) made changes to the way drugs are covered and reimbursed in Medicare. It has been ...

A study led by UCLA has discovered that JAK inhibitors could potentially prevent or reverse immune-related diabetes triggered ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...